Form D — Vesalius Longevity Labs (SPV) Inc.
0002060755-26-000018 · filed 2026-03-19
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $6,712,500
- Total sold
- $6,712,500
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Vesalius Longevity Labs (SPV) Inc.
- CIK
- 2056924
- Entity
- Corporation
- Jurisdiction
- BRITISH COLUMBIA, CANADA
- Year incorporated
- 2024
- Address
- 1500 - 1055 WEST GEORGIA STREET
VANCOUVER, A1 V6E 4N7 - Phone
- 5076666151
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Shannon Anderson · DirectorVancouver, A1 Find on LinkedIn ↗
-
Christina Phalen · Executive OfficerVancouver, A1 Find on LinkedIn ↗
View original on SEC EDGAR.